Lumeran, Jerald Kurt D.
HRN: 21-74-74 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/06/2022
08/12/2022
IVT
225
Q24
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes